Fulcrum Therapeutics
FULC
#8396
Rank
โ‚น26.11 B
Marketcap
โ‚น341.92
Share price
-0.54%
Change (1 day)
-66.20%
Change (1 year)

Earnings for Fulcrum Therapeutics (FULC)

Earnings in 2026 (TTM): -โ‚น7.95 Billion

According to Fulcrum Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น7.86 Billion a decrease over its 2024 earnings that were of -โ‚น1.84 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Fulcrum Therapeutics from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น7.95 Billion1.12%
2025 -โ‚น7.86 Billion327.39%
2024 -โ‚น1.84 Billion-82.08%
2023 -โ‚น10.26 Billion-1.31%
2022 -โ‚น10.4 Billion38.34%
2021 -โ‚น7.52 Billion13.19%
2020 -โ‚น6.64 Billion-14.97%
2019 -โ‚น7.81 Billion151.41%
2018 -โ‚น3.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.47 Billion 80.21%๐Ÿ‡บ๐Ÿ‡ธ USA